According to Sarepta Therapeutics 's latest financial reports the company's total assets are $3.26 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $3.26 B | 4.35% |
2022-12-31 | $3.12 B | -0.62% |
2021-12-31 | $3.14 B | 5.47% |
2020-12-31 | $2.98 B | 63.74% |
2019-12-31 | $1.82 B | 11.01% |
2018-12-31 | $1.64 B | 25.54% |
2017-12-31 | $1.30 B | 208.41% |
2016-12-31 | $0.42 B | 54.91% |
2015-12-31 | $0.27 B | -7.2% |
2014-12-31 | $0.29 B | 1.19% |
2013-12-31 | $0.29 B | 42.23% |
2012-12-31 | $0.20 B | 277.05% |
2011-12-31 | $54.36 M | 18.25% |
2010-12-31 | $45.97 M | -23.41% |
2009-12-31 | $60.02 M | 135.07% |
2008-12-31 | $25.53 M | -33.91% |
2007-12-31 | $38.63 M | -5.44% |
2006-12-31 | $40.86 M | -27.56% |
2005-12-31 | $56.4 M | 97.79% |
2004-12-31 | $28.51 M | -39.51% |
2003-12-31 | $47.14 M | 64.82% |
2002-12-31 | $28.6 M | -15.41% |
2001-12-31 | $33.81 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $62.12 B | 1,803.00% | ๐บ๐ธ USA |
PTC Therapeutics
PTCT | $1.89 B | -41.93% | ๐บ๐ธ USA |
Novavax NVAX | $1.79 B | -44.94% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $3.82 B | 17.32% | ๐บ๐ธ USA |
Insmed INSM | $1.32 B | -59.26% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | $0.51 B | -84.16% | ๐บ๐ธ USA |
Avidity Biosciences RNA | $0.62 B | -80.75% | ๐บ๐ธ USA |